SUMMARY
Long intergenic noncoding RNAs (lincRNAs) are important regulators of gene expression. Although lincRNAs are expressed in immune cells, their functions in immunity are largely unexplored. Here, we identify an immunoregulatory lincRNA, lincRNA-EPS, that is precisely regulated in macrophages to control the expression of immune response genes (IRGs). Transcriptome analysis of macrophages from lincRNA-EPS-deficient mice, combined with gain-of-function and rescue experiments, revealed a specific role for this lincRNA in restraining IRG expression. Consistently, lincRNA-EPS-deficient mice manifest enhanced inflammation and lethality following endotoxin challenge in vivo. lincRNA-EPS localizes at regulatory regions of IRGs to control nucleosome positioning and repress transcription. Further, lincRNA-EPS mediates these effects by interacting with heterogeneous nuclear ribonucleoprotein L via a CANACA motif located in its 3 0 end. Together, these findings identify lincRNA-EPS as a repressor of inflammatory responses, highlighting the importance of lincRNAs in the immune system.
INTRODUCTION
Cell-type-specific regulatory circuits control gene expression in complex, dynamic, and temporally regulated manners (Smale et al., 2013) . Understanding these regulatory networks is critical for a better understanding of the biological processes that contribute to human health and disease. The innate immune system represents a first line of defense against microbial infection and relies on dynamic transcriptional changes, initiated when germline-encoded pattern-recognition receptors (e.g., Toll-like receptors [TLRs] ) detect microbial products (Janeway and Medzhitov, 2002; Medzhitov and Horng, 2009 ). These receptors trigger signaling cascades that converge on well-defined transcription factors including NF-kB and interferon regulatory factors (e.g., IRF3), which induce transcription of hundreds of immune response genes (IRGs). As sustained expression of IRGs can lead to tissue damage and immune pathology, their expression must be carefully regulated (Chen and Nuñ ez, 2010) . Both transcriptional and post-transcriptional regulatory checkpoints ensure that the magnitude and duration of these events are rigorously controlled and that these pathways are turned off in a timely manner.
A large proportion of the human and mouse genome is transcribed as noncoding RNAs (ncRNAs) (Derrien et al., 2012; Djebali et al., 2012) . Among these ncRNAs, microRNAs are well-known regulators of gene expression. In addition, long noncoding RNAs (lncRNAs) also regulate gene expression in diverse biological contexts (Morris and Mattick, 2014) . To distinguish them from small noncoding RNAs, lncRNAs are arbitrarily defined as having R200 nucleotides. These RNAs can be either intergenic (between protein coding genes; long intergenic noncoding RNA [lincRNA] ), intronic, natural antisense transcripts (NATs), or transcribed from divergent enhancers and promoters (Ulitsky and Bartel, 2013) . By binding to chromatin-modifying factors, heterogeneous nuclear ribonucleoproteins (hnRNPs), or transcription factors, lncRNAs control gene transcription. Also, lncRNAs act via post-transcriptional mechanisms targeting the splicing, stability, or translation of host mRNAs (Guttman and Rinn, 2012) . Although lncRNAs have been identified in virtually all immune cells, their functions in these cells are only beginning to emerge (Atianand and Fitzgerald, 2014; Guttman et al., 2009) . For example, lincRNA-Cox2 was identified as a dynamically regulated gene induced by TLR ligands and that, in turn, acts to both promote and repress inflammatory gene expression (Carpenter et al., 2013) . Several additional lncRNAs including THRIL (Li et al., 2014) , lnc13 (Castellanos-Rubio et al., 2016) , and an antisense lncRNA, AS-IL-1a (Chan et al., 2015) , also regulate inflammatory gene expression in myeloid cells. In T cells, NeST regulates IFN-g gene transcription and persistent infection with Theiler's virus (Gomez et al., 2013) , while the lncRNA Rmrp regulates effector functions of T-helper 17 cells (Huang et al., 2015) .
In this study, we define lincRNA-EPS (erythroid prosurvival; also known as Ttc39aos1) as an important transcriptional brake that curbs inflammatory gene expression in macrophages and in mice. Macrophages and dendritic cells express lincRNA-EPS, but it is downregulated in cells stimulated with microbial ligands, including lipopolysaccharide (LPS), which signals via TLR4/ MD2. Genome-wide transcriptional analysis of macrophages from wild-type (WT) and lincRNA-EPS À/À mice revealed that lincRNA-EPS specifically repressed the expression of IRGs in both resting and TLR4-activated cells. Consistently, gain-offunction and rescue studies further defined lincRNA-EPS as a potent repressor of IRG expression. We found that lincRNA-EPS associates with chromatin and interacts with hnRNPL, a member of a larger family of heterogeneous ribonucleoproteins, to alter nucleosome positioning and repress IRGs. Finally, lincRNA-EPS À/À mice had increased susceptibility to LPS challenge in vivo. Collectively, these results demonstrate that lincRNA-EPS is an inhibitor of IRG expression, acting as a regulatory checkpoint that is downregulated prior to the inducible expression of IRGs.
RESULTS

lincRNA-EPS Is Suppressed in Macrophages Exposed to Microbial Ligands
Previous work from our lab utilized RNA sequencing to define the transcriptome of TLR2-activated bone-marrow-derived macrophages (BMDMs) and identified lincRNA-Cox2, a highly inducible lincRNA that, in turn, regulated IRG expression (Carpenter et al., 2013) . This approach also identified lncRNAs that were downregulated in macrophages stimulated through TLR2 ( Figure 1A ). Among these was an annotated lincRNA, lincRNA-EPS, originally identified as a regulator of erythrocyte differentiation (Hu et al., 2011) . As lincRNA-EPS was highly expressed in resting macrophages and downregulated following TLR ligation, we hypothesized that lincRNA-EPS might regulate IRG expression.
We employed qRT-PCR to examine the kinetics of lincRNA-EPS expression in BMDMs exposed to TLR ligands including Pam3CSK4 (TLR2/1), LPS (TLR4), and polyinosinic-polycytydilic acid (polyI:C; TLR3). The expression of lincRNA-EPS was downregulated in response to all three TLR ligands in a timedependent manner ( Figure 1B ). TLR4-mediated suppression of lincRNA-EPS was also observed in bone-marrow-derived dendritic cells (BMDCs) ( Figure 1C) . Notably, lincRNA-EPS suppression in LPS-stimulated BMDMs was dose-and time-dependent and inversely correlated with levels of the proinflammatory gene IL6 (Figures S1A and S1B ). TLR-dependent suppression of lincRNA-EPS was dependent on MyD88 and Trif since MyD88
/Trif
À/À BMDMs had a reduced ability to downregulate lincRNA-EPS ( Figure 1D ). To evaluate the role of NF-kB, a well characterized regulator of IRGs, in controlling the suppression of lincRNA-EPS, BMDMs were pretreated with DMSO (control) or BAY11-7082, an irreversible inhibitor of the IKK kinases, followed by LPS stimulation for 6 hr. The LPS (TLR4)-mediated suppression of lincRNA-EPS was impaired in BAY11-7082-treated BMDMs relative to the control cells ( Figure 1E ). Induction of IL-1a mRNA, a known target of the NF-kB pathway, was impaired in these cells ( Figure 1E ). Consistent with these findings, LPS-induced suppression of lincRNA-EPS was also impaired in IKKb-deficient BMDMs ( Figure 1F ). We also observed a similar suppression of lincRNA-EPS expression in BMDMs infected with Sendai virus or Listeria monocytogenes ( Figure 1G ) and in cells exposed to TNFa or type I interferon (IFN) ( Figure 1H ). However, stimulation of BMDMs with the anti-inflammatory cytokine IL-10, did not alter lincRNA-EPS expression or interfere with TLR4-mediated suppression of lincRNA-EPS ( Figure S1C ). We also found that macrophages express $11 lincRNA-EPS molecules per cell ( Figure S1D ). Collectively, these results indicate that lincRNA-EPS levels in macrophages are dynamically regulated in response to microbial and inflammatory triggers.
Genetic Deletion of lincRNA-EPS Leads to Enhanced Basal and TLR4-Induced Expression of IRGs in Macrophages
To test our hypothesis that lincRNA-EPS regulates IRGs, we generated mice lacking lincRNA-EPS ( Figures S2A-S2C ) by deleting the entire 4 kb genomic locus harboring lincRNA-EPS and replacing it with a neomycin resistance cassette. The lincRNA-EPS À/À animals were healthy and reproduced at expected Mendelian frequencies with no gender bias and did not manifest any gross developmental defects (data not shown). Although this lincRNA had been implicated in erythroid differentiation (Hu et al., 2011) , features of erythropoiesis including hematocrit and hemoglobin levels and red blood cell (RBC) numbers were all normal in lincRNA-EPS À/À mice (Figure S2D) . In addition the numbers of macrophages, dendritic cells (DCs), B cells, T cells, and natural killer (NK) cells were comparable in spleens of lincRNA-EPS À/À and WT animals ( Figure S2E ). To assess the impact of lincRNA-EPS deficiency on IRG expression in macrophages, we performed unbiased transcriptome profiling using RNA-seq in WT and lincRNA-EPS À/À BMDMs stimulated with LPS for 2 and 6 hr. The absence of lincRNA-EPS altered the expression of 113, 197, and 290 genes at 0, 2, and 6 hr post-LPS stimulation, respectively (R2-fold change, Q-value < 0.05) (Figure 2A ; Table S1 ). The majority of these genes were upregulated in lincRNA-EPS À/À BMDMs relative to WT BMDMs. Furthermore, mRNA levels of these genes were increased in both resting and LPS-treated conditions. A gene ontology (GO) enrichment analysis demonstrated that IRGs were significantly overrepresented in these differentially expressed genes ( Figure 2B ). The time course indicated that lincRNA-EPS regulated the expression of many IRGs in a temporal manner, since their RNA levels were often altered at specific times following LPS treatment ( Figure 2C ). Among the genes that were most significantly increased were cytokines and chemokines (Cxcl10, Cxcl9, Tnfsf10, Tnfsf8, , as well as interferon-stimulated genes (ISGs) including Ifit2, Rsad2 (Viperin), Oasl1, and multiple members of the guanylate-binding protein (GBP) family (Figures 2D and S2G) . Genes that were differentially expressed between WT and lincRNA-EPS À/À BMDMs were often IRGs that were clustered within specific chromosomal locations ( Figure 2E ). In particular, a large cluster of IRGs on chromosome 5 that included Cxcl10, Cxcl9, Plac8, and several GBP-family members was upregulated in lincRNA-EPS À/À BMDMs. We further confirmed the upregulation of the chromosome-5 gene cluster ( Figure 2F ) and others ( Figure S2H ) using qRT-PCR in both untreated and LPS-stimulated (2 and 6 hr) WT and lincRNA-EPS À/À BMDMs. Moreover, we found increased levels of Cxcl10, Ccl5, and IL6 responses in lincRNA-EPS
BMDMs at both the mRNA ( Figure 2G ) and protein levels (Figure 2H) . Notably, lincRNA-EPS À/À BMDMs did not display any changes in the expression of lincRNA-EPS neighboring genes Eps15 and Ttc39a relative to WT cells ( Figure S2I ). Furthermore, these cells also proliferated normally ( Figure S2J ). Together, these results indicate that lincRNA-EPS contributes in a specific manner to the temporal regulation of IRGs.
Gain-of-Function and Rescue Studies Define lincRNA-EPS as a Negative Regulator of Inflammatory Responses in Macrophages
We next conducted ''gain-of-function'' studies by generating macrophages that ectopically expressed lincRNA-EPS or vector control (EV Ctl) ( Figure 3A) . We stimulated these cells with LPS and measured the mRNA levels of IRGs by NanoString technology. These studies revealed that LPS-induced expression of a number of IRGs including cytokines (IL6, IL15, IL1a), chemokines (Cxcl10, Cxcl2, Ccl5, Ccl4), and antiviral ISGs (Ifit1, Oas2, Ifi204, and Rsad2/viperin) were severely impaired in lincRNA-EPS-expressing BMDMs compared to control cells ( Figure 3B ). We also confirmed these effects for some of these genes using qRT-PCR ( Figure S3A ). Also, lincRNA-EPS-mediated suppression of IRGs was observed in cells stimulated with double-stranded DNA (Figure S3B ). Ectopic expression of lincRNA-EPS also impaired LPSinduced expression of IRGs in J774.1 macrophages ( Figures S3C  and S3D ). These results collectively indicate that ectopic expression of lincRNA-EPS blocks IRG expression in macrophages. Immune genes Other genes 7 7 7 7 7 7 7 7 7 7 7 7 7 7 7 7 7 7 7 7 7 7 7 7 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 7 7 7 7 7 7 7 7 7 7 7 7 7 7 7 7 7 7 7 7 7 7 7 Error bars indicate SD. See also Figure S2 and Table S1 .
We next used retroviral transduction to restore expression of the mature RNA transcript in lincRNA-EPS
In these cells, lincRNA-EPS expression was restored to levels comparable to that seen in WT cells ( Figure 3C ). qRT-PCR analysis of Cxcl10, Ccl5, Rsad2/Viperin, and IL6 expression revealed that the LPS-induced levels of these genes, as expected, were increased in lincRNA-EPS À/À iBMDMs (immortalized BMDMs)
as compared to WT cells ( Figure 3D ). However, ectopic expression of lincRNA-EPS in these knockout (KO) cells reduced the mRNA levels of these genes back to that observed in WT cells ( Figure 3D ). Similar results were obtained for additional IRGs ( Figure S3E ). In fetal erythroblasts, lincRNA-EPS was shown to regulate the expression of pro-apoptotic genes (Hu et al., 2011) . One of the proposed target genes, Pycard, encodes ASC (apoptosis-associated speck-like protein containing CARD), a critical adaptor protein required for the assembly of the inflammasome, a caspase-1-activating complex that controls the maturation of interleukin-1b (Lamkanfi and Dixit, 2012) . The best-studied NLRP3 inflammasome is activated in response to microbial infections, environmental toxins, and endogenous danger signals (Lamkanfi and Dixit, 2012) . We therefore tested if activation of the NLRP3 inflammasome was altered in cells expressing lincRNA-EPS. Control iBMDMs and those ectopically expressing lincRNA-EPS were exposed to LPS alone or LPS together with nigericin, a pore-forming toxin, or E. coli, which both activate Nlrp3 ( Figure 3E ). In both cases, production of IL-1b was severely impaired in lincRNA-EPS-overexpressing macrophages compared to control cells ( Figure 3E ). We subsequently compared the levels of inflammasome components and substrates by immunoblotting in WT and lincRNA-EPS-overexpressing cells ( Figure 3F ). While the levels of pro-IL-1b, pro-caspase-1, and Nlrp3 were all equivalent in both cell types, the levels of ASC were greatly diminished ( Figure 3F ). Notably, genetic rescue of --aim2  lgp2  ccl5  cd40  cxcl10  cxcl2  irf1  IL6  IL1α  ifi204  ifit1  ccl4  a20  cd80  socs3  icam1  prdm1  socs1  IL15  nlrc5  rsad2  irf7 ASC in these cells fully restored IL-1b responses to levels comparable to that of control cells ( Figures 3G and 3H ).
lincRNA-EPS Is Chromatin Associated in Resting Macrophages
To understand how lincRNA-EPS regulates IRGs, we examined its localization by performing sub-cellular fractionation and analyzed levels of lincRNA-EPS by qRT-PCR. This analysis revealed that lincRNA-EPS was predominantly nuclear in resting BMDMs ( Figure 4A ). As expected, the mature b-actin and IL-1b transcripts were localized to the cytosol, while NEAT1 (a nuclear lincRNA) was confined to the nucleus. The nuclear localization of lincRNA-EPS was also confirmed using single molecule RNA fluorescent in situ hybridization (FISH) in resting primary BMDMs ( Figure 4B ). In these cells, the majority of detectable lincRNA-EPS foci (>80%) were nuclear ( Figure 4C ). Furthermore, the lincRNA-EPS FISH signal was reduced in cells exposed to LPS ( Figure 4D ).
We next determined whether lincRNA-EPS was present in free nucleoplasmic or chromatin-associated fractions. BMDMs were chemically cross-linked to preserve endogenous chromatin-RNA complexes, and the nuclear lysates subjected to sucrosegradient fractionation following sonication/DNase I treatment ( Figure 4E ). We immunoblotted histone H3 and identified chromatin-rich fractions 4-15 ( Figure 4F , top). We purified RNA from three randomly selected chromatin rich-fractions (F4, F13, and F15) and performed reverse-transcription using oligodT primers to specifically detect mature full-length transcripts and avoid detection of nascent (pre-mRNA) transcripts. Analysis by qRT-PCR revealed that lincRNA-EPS was detected across all three of these chromatin-rich fractions ( Figure 4F, bottom) . Importantly, b-actin and IL-1b were undetectable in these samples, while known chromatin associated lncRNAs (NEAT1 and JPX) and snRNAs (U1 and 7SK) were present. Further, histone H3 RNA immunoprecipitation (RIP) followed by qRT-PCR analysis of co-purified RNA confirmed that the majority of mature lincRNA-EPS was associated with chromatin ( Figure 4G ).
lincRNA-EPS Maintains a Repressed Chromatin State at IRGs
We next explored the possibility that lincRNA-EPS controls the expression of IRGs by regulating their transcription. We performed chromatin immunoprecipitation (ChIP) followed by qPCR to monitor the recruitment of RNA polymerase II (Pol II) to regulatory regions of IRGs that were upregulated in the absence of lincRNA-EPS. Pol II was recruited near the transcription start site (TSS) of Cxcl10, Ccl5, and Rsad2/Viperin in TLR4-activated cells ( Figure 5A ). However, these responses were impaired in BMDMs ectopically expressing lincRNA-EPS. We also observed similar effects at the TSS of IL6, Irf7, and ASC genes ( Figure S4A ). Consistent with these observations, the inducible recruitment of Pol II at Cxcl10, Ccl5, and Rsad2/Viperin genes in LPS-treated cells was enhanced in lincRNA-EPS
BMDMs compared to WT cells ( Figure 5B ). These results indicate that lincRNA-EPS regulates the expression of these IRGs at the level of transcription.
Based on these findings, we hypothesized that lincRNA-EPS may contribute to epigenetic silencing of IRGs to restrain their basal expression. We performed ChIP-qPCR to quantify H3K4me3, a mark of active transcription near the TSS of genes that were transcriptionally suppressed by lincRNA-EPS. H3K4me3 levels were increased in both resting and LPS-stimulated BMDMs that lacked lincRNA-EPS ( Figure 5C ). Notably, in resting cells, the H3K4me3 levels at the Cxcl10, Ccl5, Rsad2/ Viperin, IL6, Irg1, and Ifit1 TSSs were increased in lincRNA-EPS À/À BMDMs compared to WT cells ( Figure 5C ). Apparently,
lincRNA-EPS
À/À BMDMs displayed near-saturating levels of H3K4me3 marks since these levels were comparable to those detected upon LPS stimulation of WT cells. Similar patterns of elevated H3K4me3 marks were also observed for Ifit2, Gbp4, and Cxcl9 ( Figure S4B ). We also performed ChIP to monitor Pol II Ser2P, a mark of active/ongoing transcription. In unstimulated conditions, Pol II Ser2P levels were uniformly low but comparable between WT and lincRNA-EPS À/À BMDMs ( Figure 5D ). Figure S4C ). To examine the possibility that lincRNA-EPS binds to regulatory region(s) of target genes, we performed RNA antisense purification (RAP) in nuclear extracts of cross-linked resting macrophages using biotinylated, lincRNA-EPS-specific antisense RNA probes. The RNA probes specifically target lincRNA-EPS and purify the endogenous lncRNA and its associated chromatin. RAP followed by qRT-PCR analysis of the retrieved RNA showed that nearly 50% of the endogenous lincRNA-EPS was specifically pulled down in lincRNA-EPS-specific RAP conditions, relative to several controls that included no-probes and control RAP targeting the Firefly luciferase gene (Figure 5E ), as well as no-RT conditions (not shown). Highly abundant b-actin and 18S rRNA were undetectable in lincRNA-EPS RAP pull-down conditions, further confirming the specificity of lincRNA-EPS purification. In the same experiments, we examined Cxcl10, Ccl5, and ASC genomic regions since these genes were particularly affected by lincRNA-EPS in both gain-of-function and loss-of-function studies. Purified DNA was subjected to qPCR analysis, which showed that the Cxcl10, Ccl5, and ASC genomic regions near their TSS were highly enriched following lincRNA-EPS RAP, relative to the control RAP ( Figure 5F ). These results suggest that lincRNA-EPS binds (either directly or indirectly) to these gene loci. We conclude from all of these approaches that the nuclear localized lincRNA-EPS binds to regulatory regions of IRGs to prevent their expression in the absence of activating signals.
To investigate if lincRNA-EPS repressed the expression of IRGs by altering chromatin accessibility, we performed assays for transposase accessible chromatin (ATAC-seq) (Buenrostro et al., 2013) . ATAC-seq in WT and lincRNA-EPS À/À BMDMs demonstrated dynamic epigenomic changes following LPS stimulation ( Figures S4D and S4E ), including increased accessibility at promoters and gene bodies of key immune genes such as Irg1 and Ccl5 ( Figure S4F ). While global genome accessibility was largely unaltered in lincRNA-EPS À/À BMDMs relative to WT cells, several IRGs that are normally suppressed by lincRNA-EPS showed an increase in chromatin accessibility at their promoters in lincRNA-EPS À/À BMDMs at baseline ( Figure 5G ; Table   S2 ). These included genes such as Cxcl10, Irg1, and Ifit2, which show features of increased transcriptional activity in lincRNA-EPS-deficient macrophages ( Figures 5C and 5D ). This increase in chromatin accessibility at IRGs was most pronounced in unstimulated lincRNA-EPS À/À BMDMs and was comparable to that seen in WT cells after stimulation with LPS for 2 or 6 hr (Figure S4G ; Table S2 ). We next exploited the ability of ATAC-seq to capture nucleosome positions in order to assess whether increased chromatin accessibility in lincRNA-EPS À/À BMDMs reflected nucleosome depletion at target gene promoters. To this end, we mapped the nucleosome positions centered within a 1 kb window of the TSS of genes using the recently described NucleoATAC algorithm, which captures nucleosome fingerprints across regulatory regions of the genome (Schep et al., 2015) . Notably, aggregate nucleosome signals across all lincRNA-EPS-repressed IRGs (identified by RNA-seq) showed an average re-positioning of À1 nucleosome further away from their TSSs in lincRNA-EPS À/À BMDMs ( Figure 5H ; Table S3 ), while nucleosome signals across all genes (background model) were comparable between WT and lincRNA-EPS À/À BMDMs ( Figure 5H ).
These analyses indicate that the nucleosome fingerprints around the TSS of lincRNA-EPS target genes are selectively altered in lincRNA-EPS À/À cells. Interestingly, changes in nucleosome positioning were no longer evident in lincRNA-EPS À/À BMDMs compared to WT cells after 2 or 6 hr of LPS stimulation (Figure S4H) , which is analogous to the results obtained for overall chromatin accessibility changes. These changes in nucleosome positioning in lincRNA-EPS-deficient cells were better resolved by examining the genomic loci of individual target IRGs, including Cxcl10 ( Figure 5I ), Gpr84 ( Figure 5J ), Irf7, and Cxcl2 ( Figures S4I and S4J ). Although the overall chromatin accessibility at promoters of these IRGs was largely comparable between WT and lincRNA-EPS-deficient cells, there was a clear depletion of nucleosomes near the TSS of these genes in (legend continued on next page) lincRNA-EPS À/À BMDMs compared to WT. These results collectively indicate that lincRNA-EPS promotes nucleosome occupancy at target IRG promoters to repress their transcription at baseline conditions.
Identification of hnRNPL as a Binding Partner for lincRNA-EPS
We next attempted to identify the protein partners of lincRNA-EPS. To this end, we performed RNA-protein binding assays by incubating in-vitro-transcribed biotinylated lincRNA-EPS or it's antisense control RNA with nuclear extracts from BMDMs. RNA-protein complexes were captured using streptavidin magnetic beads and resolved on SDS-PAGE, and protein bands (50-75 kD) that were specifically enriched in lincRNA-EPS pulldown were subjected to mass spectrometry for identification (Figure 6A ). This approach identified six RNA-binding proteins that showed R2-fold enrichment in lincRNA-EPS pull-downs relative to antisense controls ( Figure S5A ). The most abundant RNA binding protein identified in these pull-downs was hnRNPL. The ability of hnRNPL to bind lincRNA-EPS was confirmed by western blotting ( Figure 6B ). We confirmed that lincRNA-EPS specifically interacted with hnRNPL, but not with hnRNP-A2/B1 or the DNA methyltransferase I (DNMT1) ( Figure 6B ). We also confirmed the lincRNA-EPS:hnRNPL interaction in vivo by purifying endogenous hnRNPL in macrophages and analyzing co-purified RNA by qRT-PCR ( Figures 6C and 6D ). Native hnRNPL RIP in non-cross-linked BMDMs followed by qRT-PCR analysis of co-purified RNAs showed that lincRNA-EPS was specifically enriched in hnRNPL immunoprecipitates ( Figure 6C ). Notably, in formaldehyde (FA)-cross-linked BMDMs, lincRNA-EPS showed an even higher enrichment in the hnRNPL RIP condition compared to the control ( Figure 6D ). Enrichment of lincRNA-EPS in both native and FAcross-linked hnRNPL conditions were notably higher than several other control RNAs including NEAT1 and U1 snRNA ( Figures 6C  and 6D ). These results indicate that lincRNA-EPS specifically interacts with hnRNPL both in vitro and in vivo. We next generated macrophages with knockdown of hnRNPL using three independent shRNA lines with distinct non-overlapping sequences ( Figure 6E ). TLR4-induced expression of Cxcl10 mRNA and protein levels were enhanced in hnRNPLknockdown cells compared to control shRNA cells (Figures 6F and 6G) . Similar results were obtained for Ccl5, IL6, Rsad2, Cxcl9, and Ifit1 mRNAs, as well as Ccl5 and IL6 protein levels in these experiments ( Figures S5B and S5C) . Expression of IL18, a gene that is not targeted by lincRNA-EPS, was comparable between control and hnRNPL knockdown cells ( Figure S5B ). Consistent with our findings in lincRNA-EPS KO BMDMs, hnRNPL knockdown also led to increased H3K4me3 levels at the promoters of Cxcl10, IL6, Irg1, and Ifit1 compared to control cells ( Figure S5D ). Importantly, knockdown of hnRNPL had no effect on the levels of either the unspliced or spliced (mature) forms of lincRNA-EPS ( Figure 6H) .
We also took advantage of a series of deletion mutants of lincRNA-EPS to map the hnRNPL-binding region. The results from in vitro binding assays indicated that hnRNPL interacted with the 3 0 -531 nucleotide region of lincRNA-EPS ( Figures 6I  and 6J ). This region was both necessary and sufficient to bind hnRNPL ( Figure 6J ). Consistently, ectopic expression of this region in lincRNA-EPS KO cells was sufficient to suppress Cxcl10 ( Figure 6K ). The expression of Tnfa, which is not regulated by lincRNA-EPS, was not affected in these studies. The relative expression level of WT and lincRNA-EPS deletion mutants was comparable ( Figure S5E ). We next assessed the role of CANACA motifs, commonly found in hnRNPL-interacting RNAs (Ray et al., 2013) . The lincRNA-EPS sequence contains three CANACA motifs within the 3 0 -531 region: CA1, CA2, and CA3 ( Figure 6L ). To define the contribution of individual CA motifs, we performed mutagenesis of CA1, CA2, and CA3 and analyzed hnRNPL binding and regulation of Cxcl10 in reconstituted cells. This analysis revealed that CA3 but neither CA1 nor CA2 disrupted lincRNA-EPS:hnRNPL binding ( Figure 6M ). Consistently, ectopic expression of full-length lincRNA-EPS reduced Cxcl10, Ccl5, and Ccl4 expression, while two distinct CA3 mutants (EPS_CA3a and EPS_CA3b) lost this activity ( Figure 6N ). The relative expression of WT and lincRNA-EPS mutants was comparable in these cells ( Figure S5F ). The predicted RNA secondary structure of the lincRNA-EPS 3 0 -531 region indicates that the CA3 motif spans a stem-loop region ( Figure S5G) . A similar prediction of lincRNA-EPS CA3 mutant reveals that the secondary structure around this region is vastly altered ( Figure S5G ). Mutations in a stem-loop region are more likely to disrupt the secondary structure than disrupt CA1 and CA2, which reside in the loop region. These data indicate that lincRNA-EPS interacts with hnRNPL via a CANACA motif in its 3 0 -531 region and that this motif is essential for hnRNPL binding and suppression of IRGs.
lincRNA-EPS Restrains Inflammation In Vivo
As lincRNA-EPS-deficient cells exhibit upregulated expression of IRGs under both basal and TLR4-stimulated conditions, we hypothesized that lincRNA-EPS-deficient animals would exhibit signs of heightened inflammation in vivo. We employed a model of ''endotoxic shock'' induced by intraperitoneal (i.p.) injection of E. coli LPS, characterized by high systemic levels of inflammatory mediators as well as death. WT and lincRNA-EPS À/À mice (E and F) RNA antisense purification (RAP) of endogenous lincRNA-EPS in BMDMs, followed by qRT-PCR analysis of retrieved RNA (E) and qPCR analysis of co-purified DNA (F). qPCR analysis of Cxcl10, Ccl5, and ASC genomic regions was performed using oligos directed around their TSS. #, not detected. Error bars indicate SD. See also Figure S4 and Tables S2 and S3 . were challenged with LPS i.p. for 5 hr and cytokine levels measured using multiplex assays. Following LPS challenge, lincRNA-EPS À/À animals had significantly elevated levels of inflammatory cytokines in serum ( Figure 7A ), peritoneal fluid (Figure 7B) , liver ( Figure 7C ), and spleen ( Figure 7D) . Notably, the protein levels of key immune genes including Cxcl10, Ccl5, and IL6 were significantly elevated both locally in peritoneal fluid as well as systemically in serum, spleen, and liver in lincRNA-EPS À/À animals compared to WT animals. Further, the inducible expression of IRG mRNAs was also enhanced in the spleen of lincRNA-EPS-deficient animals relative to WT animals (Figure 7E) . Flow cytometry analysis of peritoneal fluid in LPS-challenged mice however indicated that the recruitment of immune cells including neutrophils and inflammatory monocytes was comparable between WT and lincRNA-EPS À/À mice ( Figure S6 ).
We also analyzed the basal expression of a subset of lincRNA-EPS-regulated IRGs in spleens in vivo by qRT-PCR ( Figure 7F ). Interestingly, lincRNA-EPS-deficient animals showed increased levels of several IRGs relative to WT counterparts ( Figure 7F ). These results demonstrate that lincRNA-EPS plays an important role in controlling both the homeostatic and TLR4-inducible program of IRG expression in vivo. Finally, we assessed the role of lincRNA-EPS in controlling the survival of these animals. At a sub-lethal dose of LPS challenge (25 mg/kg mice weight, i.p.), lincRNA-EPS À/À mice showed significantly higher susceptibility to endotoxic-shock (p = 0.0016; log-rank [Mantel-Cox] test) since 100% of these mice succumbed to death by 30 hr ( Figure 7G , left). In contrast, only 50% of WT animals succumbed to death at this dose and time point. WT animals that failed to succumb recovered with no visible signs of illness by day 3 post-LPS challenge. We also performed similar survival studies at a low (non-lethal) dose of LPS. Notably, lincRNA-EPS-deficient animals were significantly susceptible to this non-lethal dose of LPS since only 20% of lincRNA-EPS À/À mice survived up to 5 days post-LPS challenge in contrast to 100% survival rate observed for WT mice (Figure 7G, right) . Taken together, these results demonstrate that lincRNA-EPS plays an important role in restraining lethal inflammatory responses in vivo.
DISCUSSION
Effective immune defense against pathogen challenge is dependent on a broad transcriptional program induced in macrophages and other immune cells. Enormous progress has been made in delineating how this transcriptional program is induced and regulated. Numerous factors acting at the level of receptor ligation, signaling, transcription factor activation, and chromatin state collectively coordinate the intensity and duration of these responses. Mammalian genomes also encode regulatory RNAs that control immune gene expression. While the role of microRNAs in these processes is well established (O'Connell et al., 2012) , the role of lncRNAs in the immune system are still poorly understood. In this study, we demonstrate that lincRNA-EPS downregulates IRG expression in macrophages. In resting cells, lincRNA-EPS suppresses the transcription of immune genes by controlling nucleosome positioning to maintain a repressed chromatin state. In response to microbial ligands, however, this brake is released and IRG expression induced in a temporal manner ( Figure 7H) . Notably, the kinetics of lincRNA-EPS suppression in immune cells is consistent with its role as a temporal regulator since it is expressed in resting macrophages but suppressed soon after the proinflammatory response is initiated.
Using both gain-of-function and loss-of-function approaches, we have gained critical insights into the biological functions of lncRNA-EPS at both the cellular and organismal level. Unbiased transcriptome profiling of lincRNA-EPS À/À BMDMs demonstrated that lincRNA-EPS selectively regulated the expression of a large number of immune genes, all of which play key roles in host defense against pathogens. Notably, we found that ectopic expression of lincRNA-EPS in lincRNA-EPS À/À macrophages reversed the enhanced expression of IRGs. Thus, deletion of the lincRNA-EPS DNA locus did not affect regulatory element(s) other than those controlling lincRNA-EPS expression. By controlling levels of ASC, lincRNA-EPS also downregulated inflammasome-dependent responses. Our work also demonstrates that lincRNA-EPS restrains inflammation in vivo. In response to LPS challenge, lincRNA-EPS-deficient mice produced elevated systemic levels of cytokines. Moreover, lincRNA-EPS-deficient animals were more susceptible to LPSinduced lethality compared to their WT counterparts. While we cannot be certain that all of these effects are due only to the absence of lincRNA-EPS expression in macrophages, these results provide compelling genetic evidence for in vivo functions of lincRNA-EPS in the immune system. In addition to identifying physiologic functions for this lincRNA both in isolated cells and in vivo, we provide mechanistic insights into how lincRNA-EPS controls IRG expression. Consistent with its nuclear localization, we find that lincRNA-EPS controls the basal and TLR4-inducible expressions of IRGs at the transcriptional level. The role of lincRNA-EPS in repressing gene transcription is supported by RNA pol II ChIP studies. Moreover, ATAC-seq and NucleoATAC analysis collectively indicate that lincRNA-EPS promotes a repressed chromatin state by controlling nucleosome positioning at TSSs of target IRGs in the absence of an activating signal. The evidence from our RNA FISH experiments, which reveals multiple foci throughout the nucleus, lend support to the idea that lincRNA-EPS might act directly at multiple genomic loci, rather than indirectly by affecting only major regulators in the genome.
Our mechanistic studies also indicate that lincRNA-EPS functions at least in part through its interaction with hnRNPL. Our results identify a CANACA motif in the 3 0 -531 region that is critical for both hnRNPL binding and lincRNA-EPS-dependent suppression of some IRGs. Despite the presence of three such motifs in this region, only CA tract 3 (2386-2391 nt), that spans a predicted stem-loop region is functionally important. These findings indicate that either the sequence or secondary structure of this region is involved in mediating lincRNA-EPS functions. Further studies will be required, however, to determine if all the lincRNA-EPS-dependent effects we have observed are dependent on its interaction with hnRNPL. hnRNPs are important functional partners for numerous additional lincRNAs. These include lincRNA-p21, which functions via hnRNPK (Huarte et al., 2010) IL1a   IL18   IL4   IL6  IL5  ccl2  cxcl10  cxcl1  cxcl9  irf7  stat1  nlrc5  nlrp3  tnfα  nos2  IL1ra  IL12b  IL12a  IL10  ifnα4  IL27  ccl21  nlrc4  tgfβ1 which utilizes hnRNP-A2/B1 (and hnRNP-A/B) (Carpenter et al., 2013) . It is well known that hnRNPs are involved in mRNA biogenesis. In addition, a role for hnRNPL in the transcriptional regulation of gene expression is also beginning to emerge. For instance, hnRNPL is a component of the Med23 mediator complex that plays an important role in gene transcription in epithelial cells (Huang et al., 2012) . Moreover, hnRNPL is functionally linked to the transcriptional program mediated by Aire in developing T cells (Giraud et al., 2014) . To control transcription of TNFa in THP-1 monocytes, hnRNPL also interacts with an intronic lncRNA, THRIL (Li et al., 2014) . The identification of hnRNPL as a functional binding partner of lincRNA-EPS adds further support to the role of hnRNPs in transcriptional regulation, expanding the role of these RNA binding proteins beyond their well-known functions in mRNA processing. The mechanism whereby lincRNA-EPS specifically localizes to the genomic loci of IRGs to mediate gene repression remains to be fully defined. At least three possibilities exist. First, lincRNA-EPS could interact directly with nascent pre-mRNAs at their genomic loci via RNA:RNA interactions to block their ongoing transcription. Similar interactions involving lncRNA:pre-mRNAs at specific genomic loci have been recently described for NEAT1 and MALAT1 (West et al., 2014) , as well as U1 snRNA (Engreitz et al., 2014) . Alternatively, lincRNA-EPS might interact directly with target DNA sequences to form higher-order DNA:RNA triplex structures, similar to the recently described model for lncRNA genes PARTICLE (O'Leary et al., 2015) and MEG3 (Mondal et al., 2015) . Finally, lncRNA-EPS may target genes through a ribonucleoprotein complex that does not rely on specific base-pairing with either DNA or mRNA. Instead, such RNP complexes, which in the case of lincRNA-EPS appear to involve hnRNPL, would target specific genes through a carefully coordinated set of multiprotein interactions that resemble transcription factor recruitment at specific genomic sites.
In summary, we have employed detailed molecular and genetic approaches to demonstrate that the precise regulation of lincRNA-EPS expression in macrophages is essential to control inflammatory responses by suppressing the transcription of key immune genes. Therefore, lincRNA-EPS acts as an important component of the molecular circuitry to prevent spontaneous activation of immune genes with potential implications in chronic inflammation and immune pathologies. The insights obtained from this study further advance our understanding of the physiological roles of lncRNAs in general and the growing importance of these molecules in the immune system.
EXPERIMENTAL PROCEDURES
Cell Culture and Stimulation BMDMs were differentiated from bone-marrow cells with 20% L929 supernatant for 7 days and stimulated with LPS (100 ng/mL), Pam3CSK4 (200 ng/mL), poly(I:C) (25 mg/mL), type I IFN (500 U/mL), TNFa (10 ng/mL), and IL-10 (10 ng/mL).
Generation of lincRNA-EPS Knockout Mice lincRNA-EPS KO mouse was generated by replacing the lincRNA-EPS genomic locus (4 kb) with a neomycin cassette under control of a Pgk1 promoter. lincRNA-EPS-targeting vector was electroporated into C57BL/6 mouse embryonic stem (ES) cells. Positive ES cells were injected into blastocytes to generate chimeric mice. lincRNA-EPS heterozygous mice were obtained by gamete line transmission from mating the chimeric mice with WT C57BL/6 mice.
RNA-Seq and Data Analysis
WT and lincRNA-EPS À/À BMDMs (two mice/group) were stimulated with LPS (100 ng/mL) for 0, 2, and 6 hr. RNA-seq libraries were prepared from total RNA depleted of rRNA and sequenced on Illumina Hiseq2000 as described (Heyer et al., 2015) .
Cytokine Analysis
Cytokine levels in supernatants were measured by ELISA: Cxcl10 and Ccl5 (R&D Systems), IL6, TNFa, and IL-1b (eBioscience). Multiplex protein analysis was performed by LUNARIS Mouse 12-Plex Cytokine Kit (AYOXXA Biosystems) and Mouse Cytokine/Chemokine Array 31-Plex (EVE Technologies Corporations).
ATAC-Seq
WT and lincRNA-EPS À/À BMDMs were stimulated with LPS (100 ng/mL) for 0, 2, or 6 hr in biological duplicates (two mice/group) and subjected to ATAC-seq as described (Buenrostro et al., 2013) . Briefly, nuclei pellets isolated from 50,000 cells were resuspended in 50 mL transposition buffer containing Tn5 transposase (Illumina) and incubated at 37 C for 30 min. Barcoded ATACseq libraries were sequenced on Illumina Nextseq. A detailed description of the methods is provided in the Supplemental Experimental Procedures.
ACCESSION NUMBER
The accession number for the RNA-seq data reported in this paper is ArrayExpress: E-MTAB-4088. The accession number for the ATAC-seq data reported in this paper is GEO: GSE78873. 
